Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients

PURPOSE: Although many studies have reported on the resistance mechanism of first-generation EGFR TKIs (1(st) EGFR TKIs) treatment, large-scale dynamic ctDNA mutation analysis based on liquid biopsy for non-small cell lung cancer (NSCLC) in the Chinese population is rare. Using in-depth integration...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Qinfang, Xie, Boxiong, Wu, Leilei, Ji, Xianxiu, Li, Chao, Feng, Li, Fang, Qiyu, Bao, Yuchen, Li, Jialu, Jin, Shengnan, Ding, Chunming, Li, Yixue, Zhou, Songwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304452/
https://www.ncbi.nlm.nih.gov/pubmed/30603682
http://dx.doi.org/10.1016/j.heliyon.2018.e01031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304452/
https://www.ncbi.nlm.nih.gov/pubmed/30603682
http://dx.doi.org/10.1016/j.heliyon.2018.e01031

Ejemplares similares